A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

  1. Parellada, M.
  2. San José Cáceres, A.
  3. Palmer, M.
  4. Delorme, R.
  5. Jones, E.J.H.
  6. Parr, J.R.
  7. Anagnostou, E.
  8. Murphy, D.G.M.
  9. Loth, E.
  10. Wang, P.P.
  11. Charman, T.
  12. Strydom, A.
  13. Arango, C.
Revue:
Frontiers in Psychiatry

ISSN: 1664-0640

Année de publication: 2021

Volumen: 12

Type: Article

DOI: 10.3389/FPSYT.2021.701729 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus